Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT07853508
Starting soon Not applicable

Effect of Virtual Reality on Pain and Anxiety in Women With Dysmenorrhea

NCT07853508 · tracked via the Priya Life Science Turkey tracker
Sponsor
Tokat Gaziosmanpasa University
Phase
Not applicable
Started
2026-09-30
Last updated
2026-10-07

Condition(s) studied

Primary DysmenorrheaMenstrual PainAnxiety

Investigational drug(s) / intervention(s)

Virtual Reality

Virtual Reality: A 20-minute relaxation video will be presented using a virtual reality (VR) headset. Participants will receive the intervention once daily for three consecutive days during the first three days of menstruation. The VR environment is designed to provide an immersive visual and auditory experience and to direct participants' attention away from menstrual pain.

Study summary

Dysmenorrhea, or painful menstrual periods, is a common condition that can affect daily activities and quality of life. This study aims to evaluate whether using virtual reality (VR) can reduce pain and anxiety in women with primary dysmenorrhea.

Participants will be randomly assigned to either a VR group or a 2D video group. Participants in the VR group will watch a relaxing virtual environment using a VR headset for 20 minutes once a day for three consecutive days. Participants in the 2D video group will watch the same content for the same duration and frequency using a 2D screen, such as a phone, tablet, or computer.

Pain intensity and anxiety levels will be assessed before and after each session during the three-day intervention. The study will compare changes in pain and anxiety between the two groups to evaluate the effect of VR in women with primary dysmenorrhea.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * University students, * Diagnosed with primary dysmenorrhea, * Having a regular menstrual cycle, * Willing to participate in the study, * Having no vision or hearing problems. Exclusion Criteria: * Individuals diagnosed with secondary dysmenorrhea, * Individuals experiencing chronic pelvic pain, * Individuals with a psychiatric disorder, * Individuals using hormonal therapy, * Individuals using analgesics during menstruation, * Individuals with visual or hearing impairments, * Individuals wishing to withdraw at any stage of the study, * Individuals who fill out the forms incompletely or fail to fill them out.

Primary outcome measure(s)

  • Visual Analog Scale (VAS) — 1-3. days
    This is used to quantify certain values that cannot be measured numerically. The two extremes of the parameter being evaluated are marked at either end of a 100 mm line, and the patient is asked to indicate their current status on this line by drawing a mark, placing a dot, or pointing. For pain assessment, "no pain" is written at one end and "severe pain" at the other; the patient then marks their current pain level on the line. The distance from the "no pain" end to the patient's mark represents the level of pain. Evaluation is performed by calculating the mean of the values obtained from the patients.

Trial sites (2)

FacilityCityRegionStatus
Tokat Gaziosmanpasa University Erbaa Tokat Province
Tokat Gaziosmanpasa University Erbaa Tokat Province

More Tokat Gaziosmanpasa University trials in Turkey

Kinesio Taping for the Knee and Ankle: Acute Impact on Balance, Proprioception, and ACL Risk Starting soon
Evaluation of Sexual Health Counseling for Primiparous Pregnant Women Using PLISSIT Model and Motivational Interviewing Active, not recruiting
Airway Ultrasound vs Clinical Predictors for Difficult Airway Enrolling by invitation
Teaching Electronic Fetal Monitoring to Midwifery Students With Peer Teaching Method Recruiting
The Relationship Between Oxytocin Massage in Mothers With Insufficient Milk Production in the Early Postpartum Period and Breastfeeding Self-Efficacy and Milk Let-down Reflex: A Randomized Controlled Study Recruiting

Other trials for the same condition

"Erectile Function After PCI in MI and Non-MI Patients" Recruiting
Self-Acupressure for Primary Dysmenorrhea and Premenstrual Symptoms Recruiting
Brief Title- Virtual Reality Glasses in Gynecologic Cancer Enrolling by invitation
The Effect of Using Virtual Reality Glasses and Gaming Cards on Fear, Anxiety, and Physiological Parameters in Children Administered Inhaler Medication Recruiting
Connective Tissue Massage and Music-Based Progressive Muscle Relaxation in Primary Dysmenorrhea Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07853508 on ClinicalTrials.gov ↗ ← All trials in Turkey